Document is current

Article History

Received: 31 August 2023

Revised: 11 October 2023

Accepted: 16 October 2023

First Online: 9 November 2023

Declarations

:

: Prof. Dr. Frederik L. Giesel.

: FLG is a FAPI co-inventor and is an advisor at Telix Pharma, SOFIE, ABX, and Alpha Fusion and receives royalties from iTheranostics and SOFIE Biosciences. The other authors declare no conflict of interest.

: No complex statistical methods were necessary for this paper.

: Written informed consent was not required for this study.

: Institutional Review Board approval was not required.

: N/A

: • Commentary